Keynote Conference
Samuel Yamshon, MDWeill Cornell Medicine/NewYork-Presbyterian
Thomas Marron, MD, PhDThe Tisch Cancer Institute at Mount Sinai
Medical Spotlight
Rahul Banerjee, MD, FACPFred Hutchinson Cancer Center
Sam Brondfield, MD, MAUCSF Helen Diller FamilyComprehensive Cancer Center
Jennifer Effie Amengual, MDColumbia University Hebert IrvingComprehensive Cancer Center
Danielle E. Hammond, MD, FRCP(C)The University of TexasMD Anderson Cancer Center
Amanda Nizam, MDCleveland Clinic
Ipatasertib/Anti-HER2 Therapy Is Safe and Active in PIK3CA-Mutant, HER2+ Advanced Breast Cancer
Dato-DXd Reduces High-Grade TRAEs vs Chemo in Pretreated, HR+/HER2– Advanced Breast Cancer
Vepdegestrant Plus Palbociclib Sustains Efficacy in Advanced ER+ Breast Cancer
Atezolizumab Plus Chemo Misses Mark in Early-Relapsing Unresectable TNBC